NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 5, 2019--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH) announced today that
it will release its financial results for the fourth quarter and full
year of 2018 on Tuesday, February 19, 2019, after the market close. The
Company will also provide financial guidance for 2019.
The Company will host a conference call on Wednesday, February 20, 2019,
at 8:00 a.m. ET to discuss its financial and operating results. To
access the live conference call via telephone, please dial
1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers)
and provide passcode 4056488. A live audio webcast of the call will also
be available in the Investors section of the Company’s website at www.lantheus.com.
A replay of the audio webcast will be available in the Investors section
of the Company’s website approximately two hours after completion of the
call and will be archived for 30 days.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.
(“LMI”), a global leader in the development, manufacture and
commercialization of innovative diagnostic imaging agents and products.
LMI provides a broad portfolio of products, including the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension and TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005869/en/
Source: Lantheus Holdings, Inc.
Investors
Mark Kinarney
978-671-8842
Media
Meara Murphy
978-671-8508
